Paradigm Biopharmaceuticals Ltd.ASX: PAR

Paradigm Phase 2 Ross River Virus Clinical Trial Update

Sep 14, 2017 at 3:50 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment